Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
904.95Prev. Close
896.40Volume
59Total traded value
0.01 CrUpper Circuit
1,075.65Lower Circuit
717.15Fundamentals
| Market Cap | ₹2,213Cr |
| ROE | 12.85% |
| P/E Ratio(TTM) | 21.53 |
| EPS(TTM) | 41.63 |
| P/B Ratio | 2.82 |
| Dividend Yield | 2.79% |
| Industry P/E | 41.14 |
| Book Value | 317.92 |
| Debt to Equity | 0.01 |
| Face Value | 5 |
Understand Fundamentals
Financials
About Novartis India
Novartis India Limited operates in the pharmaceuticals sector, with a diverse portfolio in Transplant, Established Medicines, Neurosciences, and Oncology, helping patients across India. The company is guided by its purpose to reimagine medicine, aiming to improve and extend people's lives through innovative healthcare solutions. Its wide-reaching network covers 113,000 healthcare professionals and 80,000 retail outlets, ensuring therapies reach even remote communities across the country.;
| Parent Organisation | Novartis India Limited |
| Managing Director | Mr. Sanjay Murdeshwar |
| BSE Symbol | 500672 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.18 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
| Wockhardt | NA (0.00%) | -195.86 |